December 6, 2023 11:22 AM EST

Ten63’s deal with Boehringer; Coya sets up agreement with Dr. Reddy’s; ReNAgade’s layoffs

Ryan Cross

Senior Science Correspondent

Jaimy Lee

Deputy Editor

Kyle LaHucik

Senior Reporter

Ten63 Therapeutics’ drug discovery deal with Boehringer Ingelheim: The Durham, NC-based startup, which is using generative AI to develop small molecule medicines, said the agreement …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ten63’s deal with Boehringer; Coya sets up agreement with Dr. Reddy’s; ReNAgade’s layoffs

Ryan Cross

Senior Science Correspondent

Jaimy Lee

Deputy Editor

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

Are programs with compounded GLP-1s safe for your population?

Ten63’s deal with Boehringer; Coya sets up agree­ment with Dr. Red­dy’s; Re­NA­gade’s lay­offs

Senior Science Correspondent

Deputy Editor

Senior Reporter

Sign up to read this article for free.

Ten63’s deal with Boehringer; Coya sets up agreement with Dr. Reddy’s; ReNAgade’s layoffs